| Dr Philip Lortz, MD | |
|
1855 Se Port St Lucie Blvd, Port St Lucie, FL 34952-5530 | |
| (772) 288-6300 | |
| (772) 288-6374 |
| Full Name | Dr Philip Lortz |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1855 Se Port St Lucie Blvd, Port St Lucie, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043226061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME66421 (Florida) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | ME66421 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Philip Lortz, MD Po Box 2229, Stuart, FL 34995-2229 Ph: (772) 288-6300 | Dr Philip Lortz, MD 1855 Se Port St Lucie Blvd, Port St Lucie, FL 34952-5530 Ph: (772) 288-6300 |
News Archive
A new phase 3 randomized clinical trial overseen by CU Cancer Center member Chad Rusthoven, MD, and Vinai Gondi, MD, from Northwestern University, is testing whether a new treatment approach could result in improved outcomes for patients with small cell lung cancer (SCLC) that has spread to the brain.
Bupa has announced the launch of the first part of its new health section online at bupa-intl.com, featuring more interactive content and 50 medical factsheets for an international audience.
CSIRO's Chief Executive Officer, Dr Geoff Garrett, today welcomed the Federal Government's budget decision to reinstate three-year base-line funding for CSIRO.
Cellectis bioresearch, the French genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that the companies have entered into an agreement for the development and commercialization of a bioengineered cell line.
The treatment of allergic rhinitis is shown to improve co-existing conditions including conjunctivitis, asthma, sinusitis, otitis media with effusion (fluid in the middle ear) and sleep disorders according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
› Verified 9 days ago
Tagrid Adili, MD PA Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 463 Nw Prima Vista Blvd, Port St Lucie, FL 34983 Phone: 772-335-1882 Fax: 772-807-7169 | |
Dr. Ana Suarez, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8501 Belfry Pl, Port St Lucie, FL 34986 Phone: 786-285-6410 | |
Whitney Evan Mayberry, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10000 Sw Innovation Way, Port St Lucie, FL 34987 Phone: 772-345-8100 | |
Dr. Bruce V Ouellette, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10000 Sw Innovation Way, Port St Lucie, FL 34987 Phone: 954-345-8100 | |
Charles A. Buscema, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 266 Nw Peacock Blvd Ste 102, Port St Lucie, FL 34986 Phone: 772-618-0505 Fax: 772-618-4692 | |
Tracey E Cerbone, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1651 Se Tiffany Ave, Ste 102, Port St Lucie, FL 34952 Phone: 772-398-1824 Fax: 772-335-2422 | |
Dr. Edward F Kellenberger, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10050 Sw Innovation Way Ste 102, Port St Lucie, FL 34987 Phone: 772-344-3811 Fax: 772-335-2422 |